This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Endourology
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • AMA Interim 2023
      • SUO 2023
      • ESMO 2023
      • IBCN 2023
      • ASTRO 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Beyond the Abstracts
  3. Urologic Oncology

Prostate Cancer

Beyond the Abstracts
Molecular Genetics of Prostate Cancer and Role of Genomic Testing - Beyond the Abstract January 6, 2023
How Well Do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis - Beyond the Abstract January 4, 2023
Neoadjuvant 177Lu-PSMA-I&T Radionuclide Treatment in Patients with High-Risk Prostate Cancer Prior to Radical Prostatectomy: A Single Arm Phase I Trial - Beyond the Abstract December 15, 2022
The Cell-Free DNA Methylome Captures Distinctions Between Localized and Metastatic Prostate Tumors - Beyond the Abstract December 12, 2022
The Current Role of Precision Surgery in Oligometastatic Prostate Cancer - Beyond the Abstract December 8, 2022
Surgical Planning for iT3 Prostate Cancer: How to Estimate Whether Preoperative MRI is Misleading You - Beyond the Abstract December 7, 2022
Skeletal-Related Events after Abiraterone or Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Population-Based Study Using the SEER-Medicare Linked Dataset - Beyond the Abstract November 22, 2022
Better Taught, Better Learned: The Surgical Learning Curve for Biochemical Recurrence after Robot-Assisted Radical Prostatectomy - Beyond the Abstract November 21, 2022
The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: An Indirect Comparison - Beyond the Abstract November 16, 2022
Delphi Study to Identify Consensus on Patient Selection for Hydrogel Rectal Spacer Use During Radiation Therapy for Prostate Cancer in the UK - Beyond the Abstract November 8, 2022
Diagnostic Performance of PSMA-PET-Targeted Biopsy for the Detection of Clinically Significant Prostate Cancer: A Systematic Review Meta-Analysis - Beyond the Abstract November 3, 2022
Optical Genome Mapping Identifies Clinically Relevant Genomic Rearrangements in Prostate Cancer Biopsy Sample - Beyond the Abstract November 2, 2022
Prostate Cancer in Australia: The Paradox of Falling Localized Disease Rates yet Continued Mortality Reduction - Beyond the Abstract October 19, 2022
Chemotherapy and Advanced Androgen Blockage, Alone or Combined, for Metastatic Hormone-Sensitive Prostate Cancer a Systematic Review and Meta-Analysis - Beyond the Abstract October 19, 2022
Post-Diagnostic Health Behaviour Scores in Relation to Fatal Prostate Cancer - Beyond the Abstract October 13, 2022
Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer - Beyond the Abstract October 13, 2022
Association of Prostate Volume and the Incidence of Prostate Cancer Determined on MRI-Fusion Biopsy: A systemic Review - Beyond the Abstract October 6, 2022
The Future of PSMA PET and WB MRI as Next-Generation Imaging Tools in Prostate Cancer - Beyond the Abstract September 28, 2022
The Effect of Salvage Radiotherapy on Survival, Functional Outcomes and Quality of Life in Men with Persistent PSA after Robot-assisted Radical Prostatectomy; Which Patient Benefits More?- Beyond the Abstract September 27, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials - Beyond the Abstract September 22, 2022
Page 6 of 52
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free